NCT04376216 (PRAISE) is a Phase 4 clinical trial of Prednisone in Acute Tubulo-Interstitial Nephritis, sponsored by Region MidtJylland Denmark.

Who is sponsoring NCT04376216?

NCT04376216 is sponsored by Region MidtJylland Denmark.

What drugs are being tested in NCT04376216?

Interventions in NCT04376216: Prednisone.

What condition does NCT04376216 study?

NCT04376216 studies Acute Tubulo-Interstitial Nephritis.

Is NCT04376216 still recruiting?

NCT04376216 is currently recruiting now. Last updated 30 December 2020.

Last reviewed 2020-12-30 · How we verify

NCT04376216: PRAISE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prednisolone Treatment in Acute Interstitial Nephritis

Recruiting now Phase 4 Last updated 30 December 2020

What this trial tests

Phase 4 trial testing Prednisone in Acute Tubulo-Interstitial Nephritis in 110 participants. Currently enrolling.

Timeline

1 September 2017

Primary endpoint
1 September 2026

1 September 2027

Quick facts

Lead sponsor	Region MidtJylland Denmark
Phase	Phase 4
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	110
Start date	1 September 2017
Primary completion	1 September 2026
Estimated completion	1 September 2027
Sites	1 location across Denmark

Drugs / interventions tested

Prednisone (prednisone) — full drug profile →

Conditions studied

Acute Tubulo-Interstitial Nephritis — all drugs for Acute Tubulo-Interstitial Nephritis →

Sponsor

Region MidtJylland Denmark

Who can join

18 and older, any sex, with Acute Tubulo-Interstitial Nephritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Prospective randomized trial with a primary objective to investigate the effect ofprdenisolone treatment in acute interstitial nephritis

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Prednisolone treatment in acute interstitial nephritis (PRAISE) - protocol for the randomized controlled trial.
Mose FH, Birn H, Hoffmann-Petersen N, Bech JN. · · 2021 · cited 16× · PMID 33933012 · DOI 10.1186/s12882-021-02372-4
Acute Interstitial Nephritis Triggered by a Novel Anti-CD25 Antibody-Drug Conjugate, Camidanlumab Tesirine.
Li NL, Flores K, Prosek J, Brodsky SV, et al · · 2022 · cited 1× · PMID 35257078 · DOI 10.1016/j.ekir.2021.11.025

Verify or expand the search:

Other trials of Prednisone

Trials testing the same drug.

NCT07444710 — Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) · Phase 1 · not yet recruiting
NCT07072585 — Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leuk · Phase 2, PHASE3 · not yet recruiting
NCT06738368 — Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombin · Phase 2 · recruiting
NCT07493148 — Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL · Phase 2 · recruiting
NCT07278856 — Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphoma · Phase 1 · not yet recruiting

Other Region MidtJylland Denmark trials

Trials by the same sponsor.

NCT05614297 — Agreement Between Rolimeter and Lachmeter in Patients With ACL Injury · unknown
NCT05621512 — Workplace Intervention Among Pregnant Hospital Employees · NA · unknown
NCT04695002 — Can a Digital Tooll Facilitate Shared Decision-making and Increase Self-efficacy in Vocational Rehabilitation? · terminated
NCT04367714 — Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19 · unknown
NCT03454802 — Passive Leg Raising - an Important Diagnostic Manoeuvre · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04376216 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Region MidtJylland Denmark
Last refreshed: 30 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04376216.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing